Detalles de la búsqueda
1.
Efficacy and safety of immune checkpoint inhibitors combined with recombinant human endostatin and chemotherapy as the first-line treatment of advanced non-small-cell lung cancer.
Future Oncol
; 19(2): 147-158, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779488
2.
Immunotherapy combined with rh-endostatin improved clinical outcomes over immunotherapy plus chemotherapy for second-line treatment of advanced NSCLC.
Front Oncol
; 13: 1137224, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37035161
Resultados
1 -
2
de 2
1
Próxima >
>>